Pay in 4 interest-free payments of $5.67 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
In a 4-week controlled trial of VYVANSE in pediatric patients ages 13 to 17 years, mean weight loss from baseline to endpoint was -2.7, -4.3, and -4.8 lbs., respectively, for patients receiving 30 mg, 50 mg, and 70 mg of VYVANSE, compared to a 2.0 pound weight gain for patients receiving placebo
Neurotherapeutics 10 , 251261 (2013)
Robust and precise knowledge distillation-based novel context-aware predictor for disease detection in brain and gastrointestinal
Trinh, J
US$ 29.20
US$ 26.26
US$ 25.80
US$ 22.96
US$ 22.27
.png)
US$ 24.63
US$ 26.93
US$ 28.18
US$ 28.47
US$ 21.01
